Lexaria Bioscience Corp (LEXX)

3.13 +0.13 (+4.33%) USD  |  NASDAQ  |  May 03, 16:00
3.11 -0.02 (-0.64%) After-Hours: 20:00
More

Lexaria Bioscience Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for LEXX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2022. Upgrade now.
Date Value
April 29, 2024 --
March 07, 2024 --
March 05, 2024 --
January 17, 2024 --
Date Value
November 28, 2023 --
July 21, 2023 --
April 20, 2023 --
April 19, 2022 --

Revenue Estimates for Next Quarter Range, Past 5 Years

--
Minimum
Jul 21 2023
Upgrade
Maximum
Apr 20 2023
Upgrade
Average
--
Median
Jul 21 2023

Revenue Estimates for Next Quarter Benchmarks

Aurinia Pharmaceuticals Inc Upgrade
Sunshine Biopharma Inc Upgrade
Acasti Pharma Inc Upgrade
Edesa Biotech Inc Upgrade
Xenon Pharmaceuticals Inc Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade